- Home
- AUID vs ANTX Comparison
AUID vs ANTX Comparison
Compare AUID & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUID | ANTX |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 31.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | AUID | ANTX |
|---|---|---|
| Price | $1.69 | $1.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 16.9M | 72.6K |
| Earning Date | 03-12-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,834,458.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 141.81 | N/A |
| 52 Week Low | $0.84 | $1.00 |
| 52 Week High | $9.58 | $1.55 |
Technical Indicators
Market Signals| Indicator | AUID | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 42.36 |
| Support Level | $1.67 | $1.06 |
| Resistance Level | $1.88 | $1.14 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 48.27 | 12.11 |
Price Performance
Historical ComparisonAbout AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.